Pandion Therapeutics, Inc. Income Statement 2011-2024 | PAND

Annual Income Statement Pandion Therapeutics, Inc.

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	419 M	-	-	-	-	-	-	-	-	-
Shares	23.3 M	-	-	-	-	-	-	-	-	-
Net Income	-38.1 M	-21.9 M	-10.9 M	-	-	-	-	-	-	-
Revenue	8.78 M	967 K	-	-	-	-	-	-	-	-
EBITDA	-37.4 M	-22 M	-11 M	-	-	-	-	-	-	-
Operating Expenses	46.7 M	23.2 M	11 M	-	-	-	-	-	-	-
General and Administrative Expenses	12.8 M	5.01 M	2.66 M	-	-	-	-	-	-	-

All numbers in USD currency